Japanese Healthcare Startup Ubie Raises $45M for AI Symptom Checker

The new funding will enable Ubie to accelerate its growth and strengthen its presence in the U.S., following strong interest and traction in that market. To date, Ubie has raised $76 million in total. It will also focus on expanding its business to the U.S. in order to apply the technology it has developed in Japan, one of the leading countries in the medical field. This is the second overseas corporation following Singapore. The decision follows the fact that the number of users has been increasing steadily since the release of the AI symptom checker in April 2022 in the U.S. The establishment of the local subsidiary will further strengthen the partnership with U.S. pharmaceutical companies, as well as the products, including hiring local people in the U.S. Ubie is a Japanese health-tech startup founded by a medical doctor and an engineer in 2017.